© 2024 Stocks Today
Xeris Biopharma announced a total revenue of $163.9 million for the fiscal year ending on March 6, 2024. The company...
Creative Medical Technology Holdings, Inc. announced on March 6, 2024, that they have been granted FDA Orphan Drug Designation for...
Xeris Biopharma Holdings (NASDAQ:XERS) announced their fourth-quarter financial results on March 6, 2024. The company reported a GAAP EPS of...
Trinity Capital Inc. (NASDAQ: TRIN) has announced impressive financial results for the fourth quarter of 2023. The company's earnings per...
Gleaming with optimism, Guggenheim analyst Robert Drbul reaffirms his Buy rating on Target (NYSE:TGT) as he boosts the price target...
United Natural Foods has revised its fiscal year 2024 forecast on March 6, 2024. The company has narrowed its projected...
On March 6, 2024, analyst Andrew Mok from Barclays started covering Surgery Partners (NASDAQ: SGRY) with an Equal-Weight rating and...
Xeris Biopharma Holdings, Inc. has recently completed a significant financial restructuring on March 6, 2024. The company successfully refinanced its...
Target Corporation (NYSE: TGT) impressed investors with its robust fourth-quarter earnings report released on March 6, 2024. The company saw...
Cricut, a leading company in the crafting industry, released its Q4 earnings report on March 5, 2024, at 04:05 PM....
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.